P04.03 Extent of surgery improves the overall survival independently of imaging characteristics in newly diagnosed glioblastoma

द्वारा Capellades, J., Puig, J., Domenech, S., Diaz, R., Oleaga, L., Pujol, T., Camins, A., Majos, C., de Quintana, C., Balana, C.
में प्रकाशित Neuro Oncol (2017)

P05.81 Neurocognitive assessment in cancer patients without central nervous system disease treated with bevacizumab at week 34: an observational transversal multi-centric pilot stu...

द्वारा Panciroli, C, Lucente, G, Cecilia, O, Quiroga, V, Carcereny, E, Pardo, J, Romeo, M, Velarde, J, Villa, S, Balaña, C
में प्रकाशित Neuro Oncol (2018)

Extended-schedule dose-dense temozolomide in refractory gliomas

द्वारा Berrocal, A., Perez Segura, P., Gil, M., Balaña, C., Garcia Lopez, J., Yaya, R., Rodríguez, J., Reynes, G., Gallego, O., Iglesias, L.
प्रकाशित 2009

SEOM clinical guidelines for anaplastic gliomas (2017)

द्वारा Balañá, C., Alonso, M., Hernandez, A., Perez-Segura, P., Pineda, E., Ramos, A., Sanchez, A. R., Teixidor, P., Verger, E., Benavides, M.
में प्रकाशित Clin Transl Oncol (2017)

Correction to: SEOM clinical guidelines for anaplastic gliomas (2017)

द्वारा Balañá, C., Alonso, M., Hernandez-Lain, A., Perez-Segura, P., Pineda, E., Ramos, A., Sanchez, A. R., Teixidor, P., Verger, E., Benavides, M.
में प्रकाशित Clin Transl Oncol (2018)

P17.04 RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBL...

द्वारा Balaña, C., Peñas, R. de las, Sepúlveda, J., Gil, M. Gil, Luque, R., Gallego, O., Reynes, G., Herrero, A., Perez-Segura, P., Berrocal, A.
प्रकाशित 2014

2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary

द्वारा Losa, F., Iglesias, L., Pané, M., Sanz, J., Nieto, B., Fusté, V., de la Cruz-Merino, L., Concha, Á., Balañá, C., Matías-Guiu, X.
में प्रकाशित Clin Transl Oncol (2018)

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry

द्वारा Gallego, Oscar, Cuatrecasas, M., Benavides, M., Segura, P. P., Berrocal, A., Erill, N., Colomer, A., Quintana, M. J., Balaña, C., Gil, M., Gallardo, A., Murata, P., Barnadas, A.
प्रकाशित 2013

Erratum to: Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry

द्वारा Gallego, Oscar, Cuatrecasas, M., Benavides, M., Segura, P. P., Berrocal, A., Erill, N., Colomer, A., Quintana, M. J., Balaña, C., Gil, M., Gallardo, A., Murata, P., Barnadas, A.
में प्रकाशित J Neurooncol (2014)

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study

द्वारा López-Pousa, A, Losa, R, Martín, J, Maurel, J, Fra, J, Sierra, M, Casado, A, García del Muro, J, Poveda, A, Balañá, C, Martínez-Trufero, J, Esteban, E, Buesa, J M
प्रकाशित 2006

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A...

द्वारा Poveda, A., López-Pousa, A., Martín, J., Del Muro, J. García, Bernabé, R., Casado, A., Balañá, C., Sanmartín, O., Menéndez, M. D., Escudero, P., Cruz, J., Belyakova, Elena, Menéndez, D., Buesa, J. M.
प्रकाशित 2005

P14.58 Extending adjuvant temozolomide longer than six cycles doesn’t add any benefit to glioblastoma patients according to the randomized GEINO-014 TRIAL

द्वारा Balana, C, Sepulveda, J, Pineda, E, Vaz, M, Mesia, C, Fuster, J, Girones, R, Muñoz-Langa, J, Navarro, M, Alonso, M, Gil Gil, M, Herrero, A, Estival, A, Gallego, O, Peralta, S, Olier, C, Pérez-Segura, P, Covela, M, Martinez García, M, Domenech, M, Carrato, C, Sanz, C, Velarde, J, Berrocal, A, Luque, R, De las Peñas, R, Del Barco, S
में प्रकाशित Neuro Oncol (2019)